文献速递遗传性与小管间质肾病肾小球疾病

Glis3 是常染色体显性多囊肾病囊肿进展的修饰基因

Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2025-12-16

该研究在小鼠模型中探讨 Glis3 与 Pkd1 的遗传互作。肾脏选择性敲除 Glis3 本身不影响肾脏结构功能,但与 Pkd1 双敲除显著加重多囊肾病。转录组与染色质可及性分析提示 Glis3 失活导致脂肪酸代谢失调和昼夜节律调控改变。

要点

  • Glis3 与 Pkd1 双敲除较单敲除 Pkd1 显著加重小鼠多囊肾病。
  • 单独敲除 Glis3 不影响肾脏结构与功能。
  • Glis3 失活与脂肪酸代谢失调及昼夜节律调控改变相关。

核心结论

  • Glis3 是与 Pkd1 遗传互作的初级纤毛定位转录因子,可修饰肾脏上皮细胞代谢与昼夜节律功能。

研究设计与样本

  • 研究使用活细胞成像及基因蛋白表达研究分析 Glis3、Glis2 与 polycystin-1 关系。
  • 使用 Glis3 条件性敲除小鼠研究其与 Pkd1 的体内遗传互作。
  • 对 Glis3 与 Pkd1 失活等位系列模型进行 RNA-Seq 与 ATAC-Seq 分析。

主要发现

  • Glis3 的纤毛定位不受 Pkd1 突变状态影响。
  • 肾脏选择性敲除 Glis3 本身不影响肾脏结构或功能。
  • Glis3 与 Pkd1 双敲除较单敲除 Pkd1 显著加重多囊肾病。
  • 整合转录组与染色质可及性分析提示肾小管特异性 Glis3 失活导致脂肪酸代谢失调和昼夜节律调控改变。

临床怎么用

  • Glis3 可能作为常染色体显性多囊肾病囊肿进展的修饰靶点,但尚需临床验证。

局限性

  • 研究基于小鼠模型,结论外推至人类需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Dual inactivation of Glis3 and Pkd1 exacerbated polycystic kidney disease compared with Pkd1 inactivation alone in mouse models of autosomal dominant polycystic kidney disease. RNA-Seq and ATAC-Seq suggested Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation. Glis3 was involved in a transcriptional network consisting of the transcription factors HNF1 homeobox B, hepatic nuclear factor 4, alpha, and D site albumin promoter binding protein. BACKGROUND: Autosomal dominant polycystic kidney disease is caused by mutations affecting polycystin-1 or polycystin-2. The existence of a cilia-dependent cyst activation pathway has been identified by showing that structurally intact primary cilia are crucial for rapid cyst growth following loss of polycystins. We previously used translating ribosome affinity purification RNA-Seq on precystic mouse kidneys to determine a translatome that meets the criteria for cilia-dependent cyst activation. From this, we identified Glis2 as an early effector of polycystin signaling and a potential target for therapy. Here, we investigate the role of Glis3 which, while not transcriptionally altered in autosomal dominant polycystic kidney disease models, encodes a cilia-localized transcription factor belonging to the same gene family as Glis2 . METHODS: We used live cell imaging along with gene and protein expression studies to determine the relationships between Glis3, Glis2, and polycystin-1 expression. We used Glis3 conditional knockout mice to investigate the in vivo genetic interaction between Glis3 and Pkd1 . We used gene expression and chromatin accessibility analyses by RNA-Seq and ATAC-Seq, respectively, on an allelic series of Glis3 and Pkd1 inactivation models to explore the genetic relationships between the two genes. RESULTS: The ciliary localization of Glis3 was not affected by Pkd1 mutation status. Kidney selective inactivation of Glis3 by itself did not affect kidney structure or function, but dual inactivation of Glis3 and Pkd1 significantly worsened polycystic kidney disease. Integration of transcriptomic profiling and chromatin accessibility assays suggested that kidney tubule-specific Glis3 inactivation resulted in dysregulated fatty acid metabolism and alteration of circadian regulation. CONCLUSIONS: Glis3 is a primary cilium localized transcription factor that genetically interacts with Pkd1 and modifies kidney epithelial cell metabolism and circadian function.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wei Z, Gu J, Tian X, et al. Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2025. PMID: 41563804. doi:10.1681/ASN.0000000980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。